Logo

Incyte Genomics, GeneFormatics To Probe Human Protein Function

Apr 23, 2002

NEW YORK, April 23-GeneFormatics and Incyte Genomics will collaborate to probe the function of human proteins, the two companies said today.

 

Incyte will provide proprietary full-length human protein sequences to GeneFormatics, which will use its own structural proteomics technology to identify the function and structure of these proteins.

 

Incyte may use this data in its genomics patent filings. Financial details were not disclosed.

 

The collaboration will help validate GeneFormatics' technology and develop its licensing strategies, said CEO John Chiplin in a statement. The San Diego, Calif.-based company, which is privately held, uses a "functional family" approach to protein annotation that relies on structural and chemical proteomics.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.